On July 2, the 11th 2026 China Shandong (Qingdao) International Wellness Industry Expo kicked off. As a highly influential grand event for the wellness sector, the expo clearly unveiled new trends of industrial upgrading: domestic wellness solutions for middle-aged and elderly groups are rapidly advancing toward precision, functionality and technological innovation. Refined health maintenance built on natural active nutrients has become a breakthrough for the upgrade of the wellness industry.
Intestinal aging, gut microbiota imbalance, weakened immunity and chronic gastrointestinal discomfort are the most prevalent health concerns among modern middle-aged and elderly people. Traditional basic nutritional supplements such as calcium and protein fail to deliver root-cause conditioning. As core active nutritional components naturally present in breast milk, Human Milk Oligosaccharides (HMOs) feature a unique dual-regulation mechanism that helps balance the intestinal microecology.
HMOs (Human Milk Oligosaccharides) have long been widely recognized and adopted in maternal and infant nutrition. With the continuous expansion of the wellness track, the valuable breast milk-derived active nutrient is set to see its application value in senior health maintenance fully uncovered.
Longjian Bio is a core biotech brand under Langkun Technology, a publicly listed A-share enterprise. It stands among China’s pioneering domestic enterprises to hold both Chinese and U.S. dual certifications for the two flagship HMO new raw materials — 2'-FL and LNnT — and has completed full-spectrum product layout of LNT, boasting rare compliance qualification barriers in the industry.
Furthermore, Longjian Bio’s Zhuhai production base has realized stable mass production of HMOs. Its products have passed rigorous validation by leading dairy manufacturers, delivering superior cost performance and more reliable supply compared with imported raw materials.